Medical device maker Integra LifeSciences Holdings Corp said on Wednesday it has offered to buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash. Integra, which makes ...
Integra LifeSciences Holdings CorporationIART has finally come up with the news of completing Codman Neurosurgery business acquisition from Johnson & Johnson JNJ. This development was expected at the ...
Add Yahoo as a preferred source to see more of our stories on Google. By Divya Grover (Reuters) - Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman ...
Integra Lifesciences Holding Corp. has made a bid to acquire Johnson & Johnson Corp.'s (J&J) Codman Neurosurgery business for $1.05 billion in cash. The neurosurgery business is part of New Brunswick, ...
Integra LifeSciences Holdings CorporationIART recently signed a definitive agreement to sell the company's certain neurosurgery assets to healthcare products and services provider Natus Medical ...
Integra LifeSciences Holdings Corp. will purchase Johnson & Johnson’s Codman neurosurgery business for $1.05 billion, reports Reuters. Here are four things to know. 1. Integra develops products for ...
Integra LifeSciences Holdings Corp.IART1.20%increase; green up pointing triangle said Wednesday that it made an offer to buy Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion in ...
Integra LifeSciences Holdings Corp. said Wednesday that it was paying $1.05 billion in cash to buy Johnson & Johnson's Codman Neurosurgery business. Codman's devices are focused on hydrocephalus, ...
(Reuters) - Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results